MEDEX PHARMA SL
Company details
- Active NIF/CIF: B88057047
-
Telephone: Not available
-
Date of last BORME entry: 08/06/2022
-
Sector: Comercio al por mayor y al por menor. Excepto reparación de vehículos de motor
-
Address: C/ PEÑALARA 3 2 B(TORRELODONES).
-
Website: Not available
-
Featured products:
More information on MEDEX PHARMA SL
-
08/06/2022 | BORME act no.: 267463 | Register: MADRIDCeses/Dimisiones -
08/06/2022 | BORME act no.: 267463 | Register: MADRIDNombramientos
-
08/06/2022 | BORME act no.: 267463 | Register: MADRIDCambio de denominación social
-
08/06/2022 | BORME act no.: 267463 | Register: MADRIDCambio de domicilio social
-
08/06/2022 | BORME act no.: 267463 | Register: MADRIDCambio de objeto social
-
06/11/2019 | BORME act no.: 459210 | Register: MADRIDCeses/Dimisiones
-
06/11/2019 | BORME act no.: 459210 | Register: MADRIDNombramientos
-
19/04/2018 | BORME act no.: 172736 | Register: MADRIDConstitución
-
19/04/2018 | BORME act no.: 172736 | Register: MADRIDNombramientos
Other information
The CIF of MEDEX PHARMA SL is B88057047 and its business status is active. Its economic activity belongs to the CNAE 4791 - Mail order or online retail trade. Its SIC is -.
MEDEX PHARMA SL has Between 1 and 9 employees employees and an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Madrid. It has a total of 4 registration charges. Its latest announcement in Borme was published on 08/06/2022 and its last deposit of ordinary annual accounts is from the year 2023.
You can check the contact details of MEDEX PHARMA SL such as phone number, address, or website in the Company Data module.
For more information about MEDEX PHARMA SL, you can acquire one of our available financial reports, the Annual Accounts of the company, or check its payment incidents in the RAI delinquency file.
All the financial, business, and legal information we provide about MEDEX PHARMA SL comes from official sources and is updated daily.
Do you want to know more about MEDEX PHARMA SL??
Find out more about this company by consulting these reports:
